Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center

Yanina A Purim-Shem-Tov1, Normal Melgoza, Janet Haw

  • 1Department of Emergency Medicine, Rush University Medical Center, Chicago, IL 60612, USA. Yanina-Purim-Shem-Tov@rush.edu

Insights

Improving ST-elevation myocardial infarction (STEMI) care is crucial. This study highlights achieving 100% compliance with door-to-balloon times under 90 minutes through a quality improvement program.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement

Background:

  • Management of ST-elevation myocardial infarction (STEMI) presents challenges for academic institutions, particularly in urban settings with dispersed staff.
  • Timely activation of catheterization teams and efficient electrocardiogram administration are critical for reducing delays in STEMI treatment.

Purpose of the Study:

  • To describe the implementation and outcomes of a quality improvement program aimed at reducing door-to-balloon times in STEMI patients.
  • To achieve and maintain adherence to the <90-minute door-to-balloon time benchmark.

Main Methods:

  • Initiation of a quality improvement program for STEMI care in 1993, focusing initially on medication adherence (aspirin, beta-blockers, ACE inhibitors).
  • Subsequent focus on optimizing door-to-balloon times as a key performance metric.
  • Integration with the 'Get With The Guidelines' program to standardize care.

Main Results:

  • Progressive improvement in the use of guideline-directed medical therapies from 1993 to 2003-2004.
  • Achieved 100% compliance with door-to-balloon times of less than 90 minutes over the last two years of the study period.

Conclusions:

  • Sustained quality improvement efforts are effective in optimizing STEMI care protocols.
  • Achieving benchmark door-to-balloon times is feasible and critical for improving patient morbidity and mortality in STEMI management.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...